Join Vector Health at the Virtual Event on Transparency & Aggregate Spend: Spring Reporting Review from May 18-20, 2021. Marc Ussini and Ned Mumtaz, from Vector Health will have an in depth discussion on Lessons Learned, Challenges Overcome and Adaptations Made in 2020 to Ensure Continuity with Michelle Kock of Exact Sciences and Karen Snyder of MorphoSys.

Topic: Discuss Lessons Learned, Challenges Overcome and Adaptations Made in 2020 to Ensure Continuity

Register now and we will send you a discount coupon right away!
Agenda:
1 – Managing Organization’s Compliance culture
2 – An Insight to Virtual Events, including Speaker Programs and delivering Virtual Meals
3 – Innovation and Creativity in Compliance
4 – Descriptive, Prescriptive and Predictive analytics

Register Now to Claim a Discount

 


Moderators:

Ned Mumtaz

Ned Mumtaz

Ned Mumtaz has over 25 years of experience in the pharmaceutical industry. He has worked as Director for Wyeth Pharmaceuticals, Schering Plough, Eisai, and Otsuka. Additionally, he has also been a consultant and an advisor for over 50 drug, biologics and device manufacturers..

Marc Ussini

Marc

Marc has over two decades of BioPharma experience. He oversees the delivery of Vector Health’s compliance products and services. He has led the implementation of various projects impacting spend transparency for both large and small manufacturers.

Panelist:

Karen Snyder

Karen Snyder has over 7 years of experience in US and Global pharmaceutical compliance. She has served legal and compliance related roles in a variety of companies including Takeda, Morphosys, Surgical Specialties Corporation & Vertex Pharmaceuticals

Michelle Kock

Michelle Kock has over 17 years of experience in pharmaceutical compliance, having previously served senior roles in GE Healthcare and Zimmer Biomet. She currently holds the position of senior Senior Director of Compliance at Exact Sciences.